A 35-year-old man sought advice about the increased risk of cardiac complications following chemotherapy. Eight years previously, he had been successfully treated for Hodgkin"s disease with six cycles of doxorubicin, bleomycin, vinblastine and dacarbazine, and mediastinal radiotherapy. For how many years from the end of treatment will this increased risk persist?

Question

Quizplus · Accepted Answer

The increased risk of cardiac complications following chemotherapy, especially with agents like doxorubicin, and mediastinal radiotherapy, persists for more than 20 years after the end of treatment. This is due to the long-term cardiotoxic effects of these treatments.

A 35-Year-Old Man Sought Advice About the Increased Risk of Cardiac